文献速递前列腺癌

长链非编码RNA IGF2AS在人前列腺癌中作为表观遗传抑癌因子

Long Noncoding RNA IGF2AS is Acting as an Epigenetic Tumor Suppressor in Human Prostate Cancer.
PubMed 文献 · Urology · 2018-11-10

该研究评估了lncRNA IGF2AS在人前列腺癌中的表达与功能机制。IGF2AS在PCa细胞系和人类肿瘤中下调,过表达可抑制增殖、侵袭和移植瘤生长,且IGF2上调可逆转此效应。结论认为IGF2AS通过反向调控IGF2发挥抑癌作用,IGF2AS/IGF2轴可能成为治疗靶点。

要点

  • IGF2AS在PCa细胞系和人类肿瘤中表达下调。
  • 过表达IGF2AS抑制PCa细胞增殖、侵袭及移植瘤生长。
  • IGF2上调可逆转IGF2AS的抑癌功能。

核心结论

  • lncRNA IGF2AS在人前列腺癌中作为表观遗传抑癌因子,可能通过反向调控IGF2发挥作用。
  • IGF2AS/IGF2轴可能成为未来前列腺癌治疗的靶点。

研究设计与样本

  • 采用定量逆转录聚合酶链反应评估永生化PCa细胞系和原位人PCa肿瘤中IGF2AS表达。
  • 在VCaP和PC3细胞中过表达IGF2AS,评估体外增殖、侵袭及体内移植瘤效应。
  • 在IGF2AS过表达的PCa细胞中上调IGF2,评估IGF2的功能参与。

主要发现

  • IGF2AS在PCa细胞系和人类PCa肿瘤中均下调。
  • 慢病毒诱导的IGF2AS过表达在VCaP和PC3细胞中抑制体外增殖和侵袭,并抑制体内移植瘤发展。
  • IGF2AS过表达下调IGF2;IGF2上调逆转IGF2AS对PCa增殖和侵袭的抑制作用。

临床怎么用

  • IGF2AS/IGF2轴可能作为前列腺癌未来治疗靶点,但需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the expression profile and functional mechanism of long noncoding RNA (lncRNA) insulin growth factor 2 antisense (IGF2AS) in human prostate cancer (PCa). METHODS: Quantitative reverse transcriptase-polymerase chain reaction was applied to assess IGF2AS expression in immortal PCa cell lines and in situ human PCa tumors. IGF2AS was overexpressed in VCaP and PC3 cells to assess its effect on PCa cell proliferation and invasion in vitro, and xenograft in vivo. The effect of IGF2AS overexpression on IGF2 was also assessed in PCa cells. Then, IGF2 was upregulated in IGF2AS-overexpressed PCa cells to assess the functional involvement of IGF2 in IGF2AS-mediated PCa cell development. RESULTS: IGF2AS was downregulated in both PCa cell lines and human PCa tumors. In VCaP and PC3 cells, lentivirus-induced IGF2AS overexpression suppressed cancer cell proliferation and invasion in vitro, and xenograft development in vivo. IGF2 was downregulated by IGF2AS overexpression. Conversely, IGF2 upregulation revered the suppressing function of IGF2AS on PCa proliferation and invasion. CONCLUSION: LncRNA IGF2AS is acting as an epigenetic tumor suppressor in human PCa, likely through inverse regulation on IGF2. IGF2AS/IGF2 axis may be a future therapeutic target for PCa treatment.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Chen Q, Sun T, Wang F, et al. Long Noncoding RNA IGF2AS is Acting as an Epigenetic Tumor Suppressor in Human Prostate Cancer. Urology. 2018. PMID: 30423304. doi:10.1016/j.urology.2018.11.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。